These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3509363)

  • 1. Susceptibility of 89,517 gram-negative isolates to aztreonam and other antibiotics.
    Lindsay G; Woods P
    Chemioterapia; 1987 Jun; 6(2 Suppl):106. PubMed ID: 3509363
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative in-vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
    Shibl AM; Ishag AH; Durgham SM
    J Chemother; 1989 Jul; 1(4 Suppl):359-61. PubMed ID: 16312439
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro activity of Ro 17-2301, a new monobactam, against gram-negative bacteria resistant to aminoglycosides.
    Landinez R; Garcia M; Merino C
    Chemioterapia; 1987 Jun; 6(2 Suppl):112-4. PubMed ID: 3509365
    [No Abstract]   [Full Text] [Related]  

  • 4. Aztreonam in the treatment of gram-negative meningitis in children.
    Isani Z; Rehman N; Adil N; el Messidi M
    Chemioterapia; 1987 Jun; 6(2 Suppl):428-30. PubMed ID: 3334590
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro chemo-antibiotic sensitivity of gram-negative bacteria from various biological materials. Comparison between aztreonam and other agents].
    Monaci E; Monaci R; Giacalone G; Meoni S
    Minerva Med; 1987 May; 78(9):617-22. PubMed ID: 3587729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the in vitro activity of aztreonam on 1990 gram-negative bacterial strains recently isolated in Campania hospitals].
    Covelli I; Bolletti-Censi M; Fortunato A; Guarino A; Spagnoletti G; Amato G; Nani E; Anzivino D; Lavitola A; Gulletta E
    Boll Ist Sieroter Milan; 1986; 65(1):22-31. PubMed ID: 3521671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antibacterial activity of aztreonam against gram-negative bacilli isolated in 1985.
    Miyake Y; Yokoyama T; Nakano H; Kuwabara M; Yamakido M; Suginaka H
    Hiroshima J Med Sci; 1988 Sep; 37(3):115-7. PubMed ID: 3248945
    [No Abstract]   [Full Text] [Related]  

  • 8. Aztreonam in the therapy of severe gram-negative infections.
    Davies A; Stone J; Hassan A; Quarty P; Green T
    Chemioterapia; 1987 Jun; 6(2 Suppl):389-90. PubMed ID: 3509455
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibiotic sensitivity of gram-negative bacteria in intensive care units in Switzerland].
    Wüst J; Auckenthaler R; Breer C; Frei R; Heinzer I; Kamm W
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1695-700. PubMed ID: 7939535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azthreonam: in vitro activity.
    Gobernado M; Cantón E; Santos M
    Microbiol Esp; 1983; 36(3-4):123-32. PubMed ID: 6687197
    [No Abstract]   [Full Text] [Related]  

  • 11. Aztreonam: preclinical studies.
    Bonner DP; Tanaka SK; Schwind RA
    N J Med; 1986 Jan; Spec No():20-5. PubMed ID: 3456495
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro studies with aztreonam, a new monobactam antibiotic.
    Peddie BA
    N Z Med J; 1986 Apr; 99(799):249. PubMed ID: 3458073
    [No Abstract]   [Full Text] [Related]  

  • 13. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
    Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of aztreonam--a new monocyclic beta-lactam antibiotic.
    Friis H
    Dan Med Bull; 1985 Jun; 32(3):196-8. PubMed ID: 4040456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-fermenting Gram-negative bacteria of human origin. II. In vitro sensitivity of 185 strains to 17 antibiotics and chemotherapeutic agents in clinical use].
    Paredes L; Thompson L; del Canto E; Paredes L
    Rev Latinoam Microbiol; 1986; 28(2):109-16. PubMed ID: 3797861
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
    Honderlick P; Gravisse J; Dardelle D; Cahen P
    Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007).
    Patzer JA; Dzierzanowska D; Turner PJ
    J Antimicrob Chemother; 2008 Aug; 62(2):369-75. PubMed ID: 18445575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
    Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
    Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
    Thabaut A; Meyran M; Huerre M
    Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.